Literature DB >> 31894528

MicroRNA-9119 regulates cell viability of granulosa cells in polycystic ovarian syndrome via mediating Dicer expression.

Yang Ding1, Pei He1, Zhiling Li2.   

Abstract

Polycystic ovary syndrome (PCOS) is a hormonal disorder common among women of reproductive age. Although much is understood concerning the pathology of PCOS, further investigation into the influence of microribonucleic acids (miRNAs) on the proliferation of ovarian granulosa cells (GCs) is needed. This study investigated the role of specific miRNAs in ovarian dysfunction of PCOS and its effect on the proliferation of GCs. Initially, miRNA profiling was performed on the ovarian cortexes of 15 rats in which PCOS had been induced and 15 rats without PCOS (non-PCOS). This mechanical study was performed on ovarian GCs extracted from human chorionic gonadotrophin (hCG)-induced rats. Insulin was used to treat GCs to establish the PCOS cell model. Increased Equus caballus mir-9119 expression was observed and confirmed in the insulin-induced model of PCOS in GCs (GC-PCOS) as well as in the hCG-induced rats when compared to non-PCOS rats and cells. Observation and confirmation were carried out through both miRNA array and quantitative PCR. In contrast, downregulation of the nuclear factor kappa B (NFκB) p65 was observed in the PCOS cell model. Additionally, annexin V, FITC, and propidium iodide flow cytometry showed overexpression of miR-9119-induced apoptosis. In this study, we revealed that miR-9119 inhibition regulates p65 expression levels in insulin-treated GCs by binding to the 3'-untranslated of p65. Additionally, regulation of p65 expression was positively correlated with the expression of the double-stranded RNA endoribonuclease DICER. Moreover, RNA silencing/overexpression of p65 affected the functional role of miR-9119. In conclusion, GCs of PCOS, the expression of miR-9119, and targeted NFκB/p65-DICER axis are upregulated in order to maintain cell viability and prevent apoptosis, thereby promoting Anti-Müllerian hormone production in GCs. This study may provide a new understanding of the mechanism of GC dysfunction.

Entities:  

Keywords:  DICER; Ovarian granulosa cells; Polycystic ovarian syndrome; miR-9119; p65

Mesh:

Substances:

Year:  2020        PMID: 31894528     DOI: 10.1007/s11010-019-03678-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

Review 1.  Targeting apoptosis pathways in pancreatic cancer.

Authors:  Alexander Arlt; Susanne Sebens Müerköster; Heiner Schäfer
Journal:  Cancer Lett       Date:  2010-11-13       Impact factor: 8.679

2.  Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Hector F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  J Clin Endocrinol Metab       Date:  2006-08-29       Impact factor: 5.958

Review 3.  NF-κB, an active player in human cancers.

Authors:  Yifeng Xia; Shen Shen; Inder M Verma
Journal:  Cancer Immunol Res       Date:  2014-09       Impact factor: 11.151

Review 4.  Recent insights into NF-κB signalling pathways and the link between inflammation and prostate cancer.

Authors:  Daniel P Nguyen; Jinyi Li; Shalini S Yadav; Ashutosh K Tewari
Journal:  BJU Int       Date:  2014-02-20       Impact factor: 5.588

5.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

6.  Effects of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 expression.

Authors:  Mora Murri; María Insenser; Elena Fernández-Durán; José L San-Millán; Héctor F Escobar-Morreale
Journal:  J Clin Endocrinol Metab       Date:  2013-09-13       Impact factor: 5.958

Review 7.  Regulatory role of microRNAs in ovarian function.

Authors:  Tal Imbar; Iris Eisenberg
Journal:  Fertil Steril       Date:  2014-06       Impact factor: 7.329

Review 8.  IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.

Authors:  Mads Gyrd-Hansen; Pascal Meier
Journal:  Nat Rev Cancer       Date:  2010-08       Impact factor: 60.716

9.  MicroRNAs and ovarian function.

Authors:  Jason Baley; Julang Li
Journal:  J Ovarian Res       Date:  2012-02-09       Impact factor: 4.234

Review 10.  MicroRNAs in Smoking-Related Carcinogenesis: Biomarkers, Functions, and Therapy.

Authors:  Tomomi Fujii; Keiji Shimada; Tokiko Nakai; Chiho Ohbayashi
Journal:  J Clin Med       Date:  2018-05-01       Impact factor: 4.241

View more
  4 in total

Review 1.  The role of miRNAs in polycystic ovary syndrome with insulin resistance.

Authors:  Yingliu Luo; Chenchen Cui; Xiao Han; Qian Wang; Cuilian Zhang
Journal:  J Assist Reprod Genet       Date:  2021-01-06       Impact factor: 3.412

2.  Increased miR-188-3p in Ovarian Granulosa Cells of Patients with Polycystic Ovary Syndrome.

Authors:  Beibei Dai; Jun Jiang
Journal:  Comput Math Methods Med       Date:  2021-04-15       Impact factor: 2.238

3.  microRNA-194 is increased in polycystic ovary syndrome granulosa cell and induce KGN cells apoptosis by direct targeting heparin-binding EGF-like growth factor.

Authors:  Yi-Xuan Wu; Yan-Shan Lin; Si-Chen Li; Xi Yao; Mingwei Cheng; Lin Zhu; Hai-Ying Liu
Journal:  Reprod Biol Endocrinol       Date:  2021-11-23       Impact factor: 5.211

Review 4.  microRNAs and long non-coding RNAs as biomarkers for polycystic ovary syndrome.

Authors:  Mona Tamaddon; Mostafa Azimzadeh; Seyed Mohammad Tavangar
Journal:  J Cell Mol Med       Date:  2022-01-06       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.